drug company

Dr Reddy’s to buy Haleon’s nicotine replacement therapy portfolio outside US

by

Mumbai: Drug major Dr. Reddy’s Laboratories will acquire British pharma company Haleon’s global portfolio of consumer healthcare brands in the nicotine replacement therapy category outside of the US for £500 million. The Indian company’s subsidiary Dr. Reddy’s Laboratories SA will acquire the share capital of Haleon plc’s arm Northstar Switzerland SARL for a total consideration … Read more

When Yusuf Hamied defied Big Pharma in the battle against HIV/AIDS

by

Through the 1990s, Indian pharma companies had been making their mark on the world stage with their generic drugs. But it wasn’t until one legendary Indian pharma boss spoke out of turn at a conference in September 2000 organized by the European Commission in Brussels that the world sat up and took notice of the … Read more